JP2016522257A - 安定なブロムフェナク溶液 - Google Patents

安定なブロムフェナク溶液 Download PDF

Info

Publication number
JP2016522257A
JP2016522257A JP2016521511A JP2016521511A JP2016522257A JP 2016522257 A JP2016522257 A JP 2016522257A JP 2016521511 A JP2016521511 A JP 2016521511A JP 2016521511 A JP2016521511 A JP 2016521511A JP 2016522257 A JP2016522257 A JP 2016522257A
Authority
JP
Japan
Prior art keywords
solution
bromfenac
present
buffer
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016521511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522257A5 (enExample
Inventor
ブイ． シャー，マンダル
ブイ． シャー，マンダル
チョーダリー，プラフラ
バーリ，ディーパック
Original Assignee
センティス リサーチ センター
センティス リサーチ センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by センティス リサーチ センター, センティス リサーチ センター filed Critical センティス リサーチ センター
Publication of JP2016522257A publication Critical patent/JP2016522257A/ja
Publication of JP2016522257A5 publication Critical patent/JP2016522257A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016521511A 2013-06-19 2014-06-17 安定なブロムフェナク溶液 Pending JP2016522257A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1816/DEL/2013 2013-06-19
IN1816DE2013 2013-06-19
PCT/US2014/042724 WO2014204952A1 (en) 2013-06-19 2014-06-17 Stable bromfenac solution

Publications (2)

Publication Number Publication Date
JP2016522257A true JP2016522257A (ja) 2016-07-28
JP2016522257A5 JP2016522257A5 (enExample) 2017-07-13

Family

ID=51136842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521511A Pending JP2016522257A (ja) 2013-06-19 2014-06-17 安定なブロムフェナク溶液

Country Status (6)

Country Link
US (1) US20160143869A1 (enExample)
EP (1) EP3010485A1 (enExample)
JP (1) JP2016522257A (enExample)
CA (1) CA2911983A1 (enExample)
EA (1) EA201591910A1 (enExample)
WO (1) WO2014204952A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019117252A1 (ja) * 2017-12-14 2019-06-20 参天製薬株式会社 ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸またはその塩を含有する点眼剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017002042A (ja) * 2015-06-10 2017-01-05 参天製薬株式会社 点眼剤、及び点眼剤防腐効力維持方法
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法
CN115887366A (zh) * 2022-11-21 2023-04-04 山东诺明康药物研究院有限公司 一种溴芬酸钠离子敏感型原位凝胶滴眼液及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064828A1 (ja) * 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. ２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE400966B (sv) 1975-08-13 1978-04-17 Robins Co Inc A H Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror
CA1325382C (en) 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
US5603929A (en) 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
CA2560559C (en) * 2004-11-05 2013-07-02 Senju Pharmaceutical Co., Ltd. Aqueous intraocular penetration-promoting eye drop
US8778999B2 (en) * 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
US20130023575A1 (en) * 2011-07-22 2013-01-24 Kamran Hosseini Compositions and methods for the treatment of ocular surface allergies
PL2765988T3 (pl) 2011-10-12 2025-02-10 Bausch & Lomb Incorporated Kompozycja okulistyczna zawierająca bromofenak o zwiększonej biodostępności
ES2664053T3 (es) * 2012-11-19 2018-04-18 Bausch & Lomb Incorporated Composición líquida acuosa que contiene ácido 2-amino-3-(4-bromobenzoil)fenil-láctico

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064828A1 (ja) * 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. ２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019117252A1 (ja) * 2017-12-14 2019-06-20 参天製薬株式会社 ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸またはその塩を含有する点眼剤
JPWO2019117252A1 (ja) * 2017-12-14 2020-12-17 参天製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸またはその塩を含有する点眼剤

Also Published As

Publication number Publication date
CA2911983A1 (en) 2014-12-24
EP3010485A1 (en) 2016-04-27
WO2014204952A1 (en) 2014-12-24
EA201591910A1 (ru) 2016-05-31
US20160143869A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
KR20170128640A (ko) 주사용의 안정한 보존제-비함유 산동 및 항-염증 용액
BR112021012492A2 (pt) Composições farmacêuticas oftálmicas e métodos para tratar doença da superfície ocular
US20160235665A1 (en) Preservative-free ophthalmic pharmaceutical formulation
TW201503909A (zh) 含有氟喹諾酮抗生素藥物之經改良藥學組成物
JP2016522257A (ja) 安定なブロムフェナク溶液
US20230277557A1 (en) Pharmaceutical kits and their use for treating dry eye disease
GR1009040B (el) Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
US9561280B2 (en) Aqueous liquid bromfenac composition having preservative efficacy
GR1009006B (el) Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χρηση περιεχον βιματοπροστη και τιμολολη
JP6672512B2 (ja) 一酸化窒素放出プロスタミドを含有する眼科用組成物
US20170000889A1 (en) Stable bromfenac ophthalmic solution
WO2022076398A1 (en) Pharmaceutical kits and their use for treating dry eye disease
JP2025011339A (ja) 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
EP2919755B1 (en) Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
WO2014120293A1 (en) Ophthalmic formulations
US20240216323A1 (en) Topical formulations of chloroprocaine and methods of using same
US20100323978A1 (en) Non-aqueous oil delivery system for ophthalmic drugs
CN114761022B (zh) 药物组合物
HK40071854B (zh) 药物组合物
US20020077358A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
TW202412751A (zh) 含有udca或其鹽之水性醫藥組合物
JP2022103145A (ja) 高分子化合物、銀塩およびイオン性等張化剤を含有する水性点眼液
OA19516A (en) Topical formulations of Chloroprocaine.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170605

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180123

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180810